4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001019056-15-000525
CIK 0000875622operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 12:55 PM ET
Size
17.8 KB
Accession
0001019056-15-000525
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2015-04-06$39.25/sh−2,000$78,500→ 515,556 total(indirect: Footnote) - Sale
Common Stock
2015-03-20$39.15/sh−4,010$156,992→ 525,417 total(indirect: Footnote) - Sale
Common Stock
2015-04-08$39.69/sh−2,500$99,225→ 508,656 total(indirect: Footnote) - Sale
Common Stock
2014-08-14$28.85/sh−2,785$80,347→ 531,945 total(indirect: Footnote) - Sale
Common Stock
2015-03-31$39.15/sh−2,000$78,300→ 518,656 total(indirect: Footnote) - Sale
Common Stock
2015-01-05$27.05/sh−2,518$68,112→ 529,427 total(indirect: Footnote) - Sale
Common Stock
2015-03-30$38.90/sh−4,761$185,203→ 520,656 total(indirect: Footnote) - Sale
Common Stock
2015-04-01$39.00/sh−1,100$42,900→ 517,556 total(indirect: Footnote) - Sale
Common Stock
2015-04-07$39.70/sh−4,400$174,680→ 511,156 total(indirect: Footnote)
Footnotes (1)
- [F1]The above shares were sold by the Jeanette Vogel Family Trust for whom, Jeffrey K. Vogel is one of the Trustees.
Documents
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 12:55 PM ET
- Size
- 17.8 KB